Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 12, 2012 - Issue 5
Submit an article Journal homepage
197
Views
9
CrossRef citations to date
0
Altmetric
Drug Profile

Cost–effectiveness of rituximab in follicular lymphoma

Karissa M Johnston Canadian Centre for Applied Research in Cancer Control (ARCC), Vancouver, BC, Canada; Oxford Outcomes Ltd, Vancouver, BC, Canada; Canadian Centre for Applied Research in Cancer Control (ARCC), Vancouver, BC, Canada; Oxford Outcomes Ltd, Vancouver, BC, Canada
,
Corneliu Bolbocean Canadian Centre for Applied Research in Cancer Control (ARCC), Vancouver, BC, Canada; School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada; Canadian Centre for Applied Research in Cancer Control (ARCC), Vancouver, BC, Canada; School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada
,
Joseph Connors Medical Oncology, University of British Columbia, Vancouver, BC, Canada; British Columbia Cancer Agency Centre for Lymphoid Cancer, Vancouver, BC, Canada; Medical Oncology, University of British Columbia, Vancouver, BC, Canada; British Columbia Cancer Agency Centre for Lymphoid Cancer, Vancouver, BC, Canada
&
Stuart Peacock Canadian Centre for Applied Research in Cancer Control (ARCC), Vancouver, BC, Canada; School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada; Canadian Centre for Applied Research in Cancer Control (ARCC), Vancouver, BC, Canada. [email protected]
Pages 569-577 | Published online: 09 Jan 2014

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Shawn Shetty & A. Razzaque Ahmed. (2017) Rituximab in the treatment of pemphigus. Expert Opinion on Orphan Drugs 5:1, pages 99-109.
Read now
Matthew S McKinney & Anne W Beaven. (2014) Yttrium-90 ibritumomab tiuxetan in the treatment of non-Hodgkin lymphoma. Blood and Lymphatic Cancer: Targets and Therapy 4, pages 45-59.
Read now

Articles from other publishers (7)

Sara Larice, Ada Ghiggia, Luciana Bergui, Francesco Cattel, Matilde Scaldaferri, Elisa Sciorsci, Giulia Valinotti & Lorys Castelli. (2019) Aspetti psicologici e qualità della vita in pazienti con linfoma in trattamento con chemioterapia orale. PSICOLOGIA DELLA SALUTE:3, pages 77-97.
Crossref
Jinma Ren, Carl V Asche, Yaping Shou & Aaron Galaznik. (2019) Economic burden and treatment patterns for patients with diffuse large B-cell lymphoma and follicular lymphoma in the USA. Journal of Comparative Effectiveness Research 8:6, pages 393-402.
Crossref
Manaka Muneishi, Ayaka Nakamura, Katsumi Tachibana, Junko Suemitsu, Shinji Hasebe, Kazuto Takeuchi & Yoshihiro Yakushijin. (2017) Retrospective analysis of first-line treatment for follicular lymphoma based on outcomes and medical economics. International Journal of Clinical Oncology 23:2, pages 375-381.
Crossref
C. Casulo, L. Nastoupil, N.H. Fowler, J.W. Friedberg & C.R. Flowers. (2017) Unmet needs in the first-line treatment of follicular lymphoma. Annals of Oncology 28:9, pages 2094-2106.
Crossref
Amy Huang, Raman K. Madan & Jacob Levitt. (2016) Future therapies for pemphigus vulgaris: Rituximab and beyond. Journal of the American Academy of Dermatology 74:4, pages 746-753.
Crossref
Anca Prica, Kelvin Chan & Matthew Cheung. (2015) Frontline rituximab monotherapy induction versus a watch and wait approach for asymptomatic advanced-stage follicular lymphoma: A cost-effectiveness analysis. Cancer 121:15, pages 2637-2645.
Crossref
Kara HeelanShazia HassanGrace BannonSandra KnowlesScott WalshNeil H. ShearNicole Mittmann. (2015) Cost and Resource Use of Pemphigus and Pemphigoid Disorders Pre- and Post-Rituximab. Journal of Cutaneous Medicine and Surgery 19:3, pages 274-282.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.